The article, Several strains of mycoplasma have been “engineered” to become more dangerous. They are now being blamed for AIDS, cancer, CFS, MS, CJD and other neurosystemic diseases, states, “They ‘weaponize’ it and tested it on an unsuspecting public in North America.”
Who is ‘They’? The mycoplasma disease agent was developed by the US military in biological warfare experimentation, it was not made public and physicians are not aware of it. This pathogen was patented (US Patent No. 5,242,820, issued September 7, 1993) by the United States military and Dr Shyh-Ching Lo. Dr Lo is listed as the ‘Inventor’ and the American Registry of Pathology, Washington, DC, is listed as the ‘Assignee’ of ‘Pathogenic Mycoplasma’.
Mycoplasma fermentans (incognitus strain) probably comes from the nucleus of the Brucella bacterium.
Dr Maurice Hilleman, chief virologist for the pharmaceutical company Merck Sharp & Dohme, stated that this disease agent is now carried by everybody in North America and possibly most people throughout the world.
Dr Charles Engel, who is with the US National Institutes of Health, Bethesda, Maryland, stated the following at an NIH meeting on February 7, 2000: “I am now of the view that the probable cause of chronic fatigue syndrome and fibromyalgia is the mycoplasma…”
Blood Volume Test
Every human being requires a certain amount of blood per pound of body weight, and it has been observed that people with fibromyalgia, chronic fatigue syndrome, multiple sclerosis and other illnesses do not have the normal blood volume their body needs to function properly. Doctors aren’t normally aware of this. [Note: MegaQuinone increases blood volume]
Watch dog groups are tracking: Chronic Fatigue by Mosquito Vector in Punta Gorda, Florida and Ontario; Carcinogens over Winnipeg, Manitoba; BRUCELLA AND AIDS; and Gulf War syndrome all caused by MYCOPLASMA.
About the Author
Donald Scott, MA, MSc, is Adjunct Professor with the Institute for Molecular Medicine and he produces and edits the journal of Degenerative Diseases. He has extensively researched neurosystemic degenerative diseases over the past five years and has authored many documents on the relationship between degenerative diseases and a pathogenic mycoplasma called Mycoplasma fermentans. His research is based upon solid government evidence.
You may contact Donald Scott at: 190 Mountain St., Ste. 405, Sudbury, Ontario, Canada P3B 4G2. 705-670-0180.